id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-018243-hyvu9nuq	Salman, Huda	Fibrosing Alveolitis in Hematologic Malignancy Patients Undergoing Hematopoietic Cell Transplantation	2010-08-19		.txt	text/plain	6990	357	31	This chapter will address the chronic lung complications that lead to pulmonary fibrosis and persistent organ dysfunction in each context with specific focus on hematologic malignancy patients treated using HSCT. Hematologic malignancy patients treated with chemotherapy or chest wall radiation therapy, or those who proceed to receive a HSCT may develop a wide variety inflammatory noninfectious lung disorders that ultimately may lead to pulmonary fibrosis. The diagnosis of drug-induced respiratory disease often is complex because: (1)1 patients may be exposed to several pneumo-toxic drugs concurrently or in sequence due to earlier treatment failure; (2)2 time to onset of pulmonary toxicity may be delayed, making it difficult to ascertain which agent is responsible for the pulmonary reaction; (3)3 the combination of drugs to treat malignant hematologic conditions may lead to unexpected drug interactions, producing enhanced toxicity compared with the toxicity of each agent considered separately; and (4)4 radiation therapy to the chest or TBI.	./cache/cord-018243-hyvu9nuq.txt	./txt/cord-018243-hyvu9nuq.txt